News

Substitution of generic antiepileptic drugs

2016-12-12 Despite the availability of generic antiepileptic drugs (AEDs), patients and neurologists still hesitate to make a switch due to several reasons. The objectives of this… Read More »

Biosimilars: management of clinical issues

2016-12-09 How to manage clinical issues encountered with biosimilars was a topic discussed in a review of biosimilars in rheumatology by author José M Serra López-Matencio… Read More »

Payers in US view biosimilars as a lower-cost branded option

2016-12-07 Payers in the US do not expect the biosimilars market to be like the generics market and they also do not expect the US biosimilars… Read More »

A multidisciplinary perspective on biosimilars

2016-12-05 A biosimilar is an officially regulated and approved copy of an originator biological therapy. Authors Khraishi et al. aimed to provide a comprehensive review of… Read More »

FDA issues draft guidance on biosimilars labelling

2016-12-02 The US Food and Drug Administration (FDA) announced on 31 March 2016 that it had issued draft guidance for industry on labelling for biosimilars. The… Read More »

European regulatory pathways for biosimilars

2016-11-30 The European regulatory pathways for biosimilars were discussed in a review of biosimilars in rheumatology by author José M Serra López-Matencio and colleagues from the… Read More »

Impact of antidepressant generics in Europe

2016-11-28 Use of generic antidepressants may improve adherence and reduce the cost of pharmacotherapy for depression in European countries, according to a report by the Germany-based… Read More »

Biologicals: characteristics that make them unique and special

2016-11-25 The unique characteristics of biologicals were discussed in a review of biosimilars in rheumatology by author José M Serra López-Matencio and colleagues from the Universidad… Read More »

Impact of South Korea’s new drug–pricing policy on market competition

2016-11-23 In April 2012, the Korean Government implemented a new policy to try and make its multiple sourced (off-patent) market more competitive. Their objective was to… Read More »

How the biosimilars market is changing

2016-11-21 Access to high quality medicine at affordable prices without jeopardizing patients’ health is one of the key challenges in developed countries where rising life expectancy… Read More »

Page 1 of 47 1 2 3 4 5 Next »... 47
Go Back Print